“Evaluation Of The Protective Role Of Empagliflozin In Inflammation-Triggered Kidney Disease In Preclinical Settings”, Int. J. Environ. Sci., pp. 3552–3558, Sep. 2025, doi: 10.64252/pbnwgb08.